IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells.

Saved in:
Bibliographic Details
Title: IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells.
Authors: Tran CP; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia., Scurr M; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia., O'Connor L; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia., Buzzelli JN; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Ng GZ; Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia., Chin SCN; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia., Stamp LA; Department of Anatomy and Physiology, The University of Melbourne, Victoria, Australia., Minamoto T; Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan., Giraud AS; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Judd LM; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Sutton P; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Co-senior authors., Menheniott TR; Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Co-senior authors.
Source: Oncotarget [Oncotarget] 2022 Jun 01; Vol. 13, pp. 785-799. Date of Electronic Publication: 2022 Jun 01 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.28238